HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

IL-6 upregulates its own receptor on some human myeloma cell lines

Abstract : Interleukin 6 (IL-6) is the major survival factor of myeloma cells. In this study, we demonstrate that IL-6, oncostatin M (OSM) and leukemia inhibitory factor (LIF) upregulate membrane IL-6 receptor alpha (IL-6Ralpha) on OPM-2 myeloma cell line at transcriptional level. In OPM-2 cells, IL-6, OSM and LIF induce both signal transducers and activators of transcription (STAT), mitogen activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI 3-K) activation. We show that the cytokine-induced upregulation of IL-6Ralpha can be abolished by a janus kinase (JAK)-2 specific inhibitor, i.e. AG490, suggesting an involvement of the JAK/STAT pathway in this process. Finally, IL-6Ralpha upregulation was also inhibited by wortmannin, an inhibitor of the PI 3-kinase pathway. In conclusion, IL-6 can upregulate its own receptor on OPM-2 cells probably through the JAK/STAT and PI 3-kinase pathways.
Document type :
Journal articles
Complete list of metadata

Contributor : Lionel Spinelli Connect in order to contact the contributor
Submitted on : Wednesday, September 27, 2017 - 9:28:35 AM
Last modification on : Friday, October 22, 2021 - 4:38:49 AM


  • HAL Id : hal-01595828, version 1



W. Thabard, M. Collette, M. P. Mellerin, Denis Puthier, S. Barille, et al.. IL-6 upregulates its own receptor on some human myeloma cell lines. Cytokine, Elsevier, 2001, 14 (6), pp.352--356. ⟨hal-01595828⟩



Record views